Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-033660
Filing Date
2024-11-06
Accepted
2024-11-06 16:58:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20241106c_defa14a.htm DEFA14A 46773
2 EXHIBIT 2.1 ex_744074.htm EX-2.1 586393
3 EXHIBIT 10.1 ex_744075.htm EX-10.1 59706
4 EXHIBIT 99.1 ex_744076.htm EX-99.1 17537
  Complete submission text file 0001437749-24-033660.txt   711434
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 241431940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)